Remedium Lifecare Ltd — Updates, 30-05-2025: Company Update

Remedium Lifecare Limited’s secretarial audit for FY ending March 2025 highlights partial non-compliance with SEBI regulations, primarily due to the board comprising fewer than six directors throughout the period. The company has established a Singapore subsidiary, RemLife Global Pte. Ltd., commencing its first accounting year ending March 2025. Some insider trading compliance gaps were noted, specifically delays in updating the UPSI details in the Structured Digital Database software post-October 2024, which the company attributes to staff transitions and plans to rectify. No statutory auditor resignations occurred, and disclosure, policy adoption, and website maintenance requirements were generally met.